Acutely occurring symptoms in the sense of acute coronary syndrome with marker elevation (troponin) and symptoms that appeared within the last 24 hours indicative of a ST-elevation myocardial infarction or non-ST-elevation myocardial infarction
Conditions
Interventions
Group 1: Participants, in accordance with the inclusion criteria, who choose an additional integrative therapy concept (InTk)
Group 2: Participants, in accordance with the inclusion criteria, who do n
Sponsors
Gemeinschaftskrankenhaus Havelhöhe
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - acutely occurring symptoms indicative of acute coronary syndrome with marker elevation (troponin) and symptoms that appeared within the last 24 hours suggestive of ST-elevation myocardial infarction or non-ST-elevation myocardial infarction. - presence of a written consent form for the CARDIO NET registry, with or without written consent for the INTEGRATE-ACS study. - standard or additional medication therapies during INTEGRATE-ACS according to physician's treatment decisions are not exclusion criteria.
Exclusion criteria
Exclusion criteria: - occurrence of ECG changes/marker elevation indicative of acute coronary syndrome due to another treatable cause (decompensated valvular disease, tachyarrhythmia, pericarditis/pericardial effusion, pulmonary embolism) - patient's refusal to participate in the CARDIO NET registry - contraindication for additional medication on the part of the patient - pregnancy/breastfeeding - life expectancy < 6 months - manifest depression - manifest anxiety disorder - manifest psychosis - other serious conditions that significantly restrict daily physical function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implementation of a multimodal integrative non-pharmacological therapy concept (InTk) within the structure of a cardiology department in an acute care hospital, measured by the quantitative assessment of the type and number of InTk therapies conducted, as well as through surveys on patient satisfaction, their perceived benefits, and obstacles to accessing the InTk therapies | — |
Secondary
| Measure | Time frame |
|---|---|
| - Improvement in quality of life (HRQL) 12 months after the acute event compared to the control group, measured using the PHQ questionnaire, GAD-7 questionnaire, and EQ-5D-3L questionnaire - Acceptance of the integrative therapy concept in the InTK group, measured using the questionnaire during the final consultation - Better healing progress in the InTK group (treatment group) compared to the control group measured by a lower rehospitalization rate (inpatient admission due to a cardiac event) - Establishment of an internal clinical therapy registry, CARDIO NET, where the parameters listed under "data collection" from the data collection forms for individual participants are continuously documented | — |
Countries
Germany
Contacts
Public ContactFabrizio Esposito
Gemeinschaftskrankenhaus Havelhöhe Berlin, Intensiv-/Notfallmedizin und Kardiologie
Outcome results
None listed